Home Blog Pharmaceutical Litigation

Category Archive: Pharmaceutical Litigation

1 2 3 4 5
Niagara officials react to AG’s fentanyl warning

Niagara officials react to AG’s fentanyl warning

| Pharmaceutical Litigation
  County opiate task force will meet to consider further steps Niagara County officials are taking the discovery of fentanyl-laced pills that resemble prescription oxycodone pills in Western New York seriously, pledging today to devise steps to deal with the new threat. The information, revealed Thursday in a briefing by New York State Attorney General…Read the article
Attorney general warns of ‘deadly’ pills

Attorney general warns of ‘deadly’ pills

| Pharmaceutical Litigation
OPIOID CRISIS: Fentanyl pills seized during Western New York investigation. BUFFALO — Attorney General Eric T. Schneiderman has issued an urgent public health alert about a dangerous and potentially lethal new drug that has made its way into Western New York. During the course of an ongoing, coast-to-coast investigation into drug trafficking in Western New…Read the article
Mora County Files Lawsuit Against Opioid Peddlers

Mora County Files Lawsuit Against Opioid Peddlers

| Pharmaceutical Litigation
Mora County has become the first New Mexico governmental entity to seek damages against the manufacturers and distributors of opioid painkillers. Mora County Commissioners, Paula A. Garcia (Chair), George A. Trujillo, and Alfonso J. Griego unanimously voted Monday (August 14, 2017) to retain the firms of Napoli Shkolnik, PLLC (New York) and Fadduol, Cluff, Hardy…Read the article
Doctors from Lower-Tier Med Schools Prescribe More Opioids

Doctors from Lower-Tier Med Schools Prescribe More Opioids

| Pharmaceutical Litigation
Overall, doctors are still heavily prescribing opioid pain medications, which is helping to fuel the opioid epidemic in the United States. But what’s behind physicians’ prescribing habits? A new report suggests that the rank of the medical school where a doctor received initial training may have something to do with how frequently they prescribe opioids…Read the article
Shayna Sacks Appointed to Leadership Role in PPI Litigation

Shayna Sacks Appointed to Leadership Role in PPI Litigation

| Pharmaceutical Litigation
Napoli Shkolnik PLLC is proud to announce that Partner Shayna E. Sacks was named to the Plaintiffs’ Steering Committee in the In Re: Proton-Pump Inhibitor Products Liability Litigation (MDL 2789) by United Stated District Judge Claire C. Cecchi of the District of New Jersey. Ms. Sacks brings her substantial mass tort legal acumen and experience…Read the article
Rheumatoid Arthritis: Actemra Lawsuits

Rheumatoid Arthritis: Actemra Lawsuits

| Pharmaceutical Litigation
Actemra is a prescription drug that is given to patients to treat rheumatoid arthritis. While the drug is supposed to help patients overcome their pain and limitations caused by the disease, Actemra (active ingredient tocilizumab) has been linked to serious side effects, and many affected patients have taken action by filing lawsuits against Roche., Actemra’s…Read the article
New Actemra Clinical Trials Move Forward

New Actemra Clinical Trials Move Forward

| Pharmaceutical Litigation
Even as questions swirl about the drug’s safety, Roche subsidiary Genentech announced that its plans to market Actemra to sclerosis patients will move to Phase 3 clinical trials. Over the next 48 weeks, Genentech employees at over 100 worldwide sites will administer either tocilizumab or placebos to test subjects who have been diagnosed with systemic…Read the article
Testosterone Drug Lawsuits

Testosterone Drug Lawsuits

| Pharmaceutical Litigation
The number of men who use testosterone drugs to treat the condition known as low testosterone or  “low T” has increased dramatically in recent years, with an article published by Harvard Health Publications stating that “millions of American men” use a testosterone prescription. But not only may the condition of low T be one that…Read the article
National Opioid Epidemic: Fighting Back

National Opioid Epidemic: Fighting Back

| Pharmaceutical Litigation
The opioid epidemic across the United States is so severe that it has drawn national attention, with the Trump Administration recently announcing a new initiative that is aimed at addressing what it has called “the worst drug crisis” in history, as reported by The Hill. The new pilot program will track opioid prescriptions and pharmacies…Read the article
Invokana & Kidney Failure

Invokana & Kidney Failure

| Pharmaceutical Litigation
Type II diabetes is a life-threatening disease, and as such, those who suffer from type II diabetes often turn to medication for help in treating the illness. One such prescription medication is Invokana (canagliflozin), which helps to lower blood sugar by forcing the kidneys to remove sugar through urination. However, in June 2016, the FDA…Read the article
1 2 3 4 5

Contact Us

Get a free case evaluation Attorney Referral

For all other inquiry types, please Contact Us or call (844) 230-7676

GET HELP NOW